Adaptimmune Therapeutics plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (12)

Latest Posts

About This Stock More About This Stock
Which 3 Stocks Are Insiders Buying Like Crazy?
Article By: TipRanks
Wednesday, September 12, 2018 10:48 AM EST
Let’s take a closer look at GTT Communications, Adaptimmune Therapeutics and Six Flags Entertainment.
In this article: GTT, ADAP, SIX
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EST
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
3 Strong Stocks Top Insiders Are Buying Now
Article By: TipRanks
Wednesday, March 28, 2018 3:30 PM EST
Here are 3 strong stocks that insiders are buying now: TIF, OLLI and ADAP.
In this article: TIF, ADAP, OLLI
Read
Is Cascadian Therapeutics Inc (CASC) A Good Stock To Buy?
Article By: Insider Monkey
Sunday, December 18, 2016 7:59 PM EST
In this article, we take a closer look at Cascadian Therapeutics Inc. from the perspective of successful hedge funds. Is Cascadian Therapeutics Inc. a superb investment today? Hedge funds are definitely reducing their bets on the stock.
In this article: CASC, DQ, VRS, FFKT, ADAP
Read
How To Profit On The $200 Billion Immunotherapy Market
Article By: Michael A Robinson
Tuesday, March 22, 2016 6:58 AM EST
Wall Street concurs. According to Allied Market Research, the immuno-oncology market has been growing at a solid 7.1% annual clip since 2014, and it's expected to hit $110 billion by 2020.
In this article: GSK, MRK, PFE, ADAP
Read

PARTNER HEADLINES

Latest Tweets for $ADAP

No tweets yet!